Endonovo Therapeutics, Inc. SEC filings ENDV

Endonovo Therapeutics, Inc. has 502 filings in SEC EDGAR's recent list, going back to Sep 22, 2011. Its latest annual report, Form 10-K, was filed on Apr 17, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Dec 29, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Jan 3, 2024 (material agreement). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q/A Amended quarterly report Dec 29, 2023 Sep 30, 2023
10-Q Quarterly report Dec 29, 2023 Sep 30, 2023
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
10-Q Quarterly report Nov 21, 2022 Sep 30, 2022
10-Q Quarterly report Aug 22, 2022 Jun 30, 2022
10-Q Quarterly report May 19, 2022 Mar 31, 2022
10-Q Quarterly report Nov 19, 2021 Sep 30, 2021
10-Q Quarterly report Aug 23, 2021 Jun 30, 2021
10-Q Quarterly report May 24, 2021 Mar 31, 2021
10-Q Quarterly report Nov 19, 2020 Sep 30, 2020
10-Q Quarterly report Aug 19, 2020 Jun 30, 2020
10-Q Quarterly report Jun 12, 2020 Mar 31, 2020
10-Q Quarterly report Nov 19, 2019 Sep 30, 2019
10-Q Quarterly report Aug 13, 2019 Jun 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q Quarterly report Aug 13, 2018 Jun 30, 2018
10-Q Quarterly report May 18, 2018 Mar 31, 2018
10-Q/A Amended quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report Nov 7, 2017 Sep 30, 2017
10-Q Quarterly report Aug 10, 2017 Jun 30, 2017
10-Q Quarterly report May 12, 2017 Mar 31, 2017
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report Aug 12, 2016 Jun 30, 2016
10-Q/A Amended quarterly report May 27, 2016 Mar 31, 2016
10-Q Quarterly report May 20, 2016 Mar 31, 2016
10-Q Quarterly report Nov 23, 2015 Sep 30, 2015
10-Q Quarterly report Aug 19, 2015 Jun 30, 2015
10-Q/A Amended quarterly report Jun 15, 2015 Mar 31, 2015
10-Q Quarterly report May 19, 2015 Mar 31, 2015
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
10-Q Quarterly report Aug 19, 2014 Jun 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Dec 18, 2013 Sep 30, 2013
10-Q/A Amended quarterly report Aug 28, 2013 Jun 30, 2013
10-Q Quarterly report Aug 19, 2013 Jun 30, 2013
10-Q/A Amended quarterly report Jun 21, 2013 Mar 31, 2013
10-Q Quarterly report May 20, 2013 Mar 31, 2013
10-Q Quarterly report Nov 29, 2012 Sep 30, 2012
10-Q Quarterly report Aug 20, 2012 Jun 30, 2012
10-Q Quarterly report May 21, 2012 Mar 31, 2012

Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ENDV (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woodland Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1528172
Former names
Hanover Portfolio Acquisitions, Inc. (until Jan 24, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.